$8.3B package for coronavirus approved

Congress approved an $8.3 billion package to fight the spread of coronavirus and respond to the crisis.

While the vast majority of the cases of coronavirus, dubbed COVID-19, remain in China, at least 60 other locations have confirmed cases. In the U.S., nine deaths and 80 confirmed cases have been reported by the CDC as of March 4. The CDC also expects more cases to pop up in the nation as testing advances and accelerates.

The coronavirus package includes $950 million to states, localities, territories and tribes to help with virus surveillance, lab testing and infection control. $3 billion has been earmarked for research and development of COVID-19 vaccines, therapeutics and diagnostics. Other provisions for waiving Medicare telehealth restrictions were also included, as telehealth could potentially help diagnose the virus without spreading it further.

Another $2.2 billion was allocated for public health measures to prevent the spread of the virus, while $1 billion will be sent overseas to aid in preventing further spread under the House bill.

The spending package, which was passed by the house on March 4, will go to the Senate for approval and, ultimately, President Trump’s desk for signature. The Trump administration originally asked Congress to approve $2.5 billion in funding to fight the disease, but the figure was met with criticism from experts.

Health agencies are also ramping up testing for the virus domestically.

"We have more than 2,500 kits that are being distributed around the country this week that will make more than 1.5 million tests available at hospitals that have requested them and in areas of the country that have been particularly impacted by the coronavirus," Vice President Mike Pence, who is heading up the U.S. response to COVID-19, said in a statement March 4.

 

Amy Baxter

Amy joined TriMed Media as a Senior Writer for HealthExec after covering home care for three years. When not writing about all things healthcare, she fulfills her lifelong dream of becoming a pirate by sailing in regattas and enjoying rum. Fun fact: she sailed 333 miles across Lake Michigan in the Chicago Yacht Club "Race to Mackinac."

Around the web

The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply.

The 24 members of the House Task Force on AI—12 reps from each party—have posted a 253-page report detailing their bipartisan vision for encouraging innovation while minimizing risks. 

Merck sent Hansoh Pharma, a Chinese biopharmaceutical company, an upfront payment of $112 million to license a new investigational GLP-1 receptor agonist. There could be many more payments to come if certain milestones are met.